Back to
NATIXIS
XBIShowing 6 of 16 quarters
Position history for
NATIXIS's holdings in State Street SPDR SP Biotech ETF
Yes. Natixis holds 492,616 shares of XBI (State Street SPDR SP Biotech ETF), worth $78M, as of its Q2 2026 13F filing. It increased the position by 3,812 shares (+0.8%) from Q1 2026. Natixis has held XBI since Q1 2025, across 6 quarterly 13F filings. XBI is 0.3% of Natixis' reported 13F portfolio.
Current Value
$78M
Current Shares
492,616
Total Value Change
+$37.7M
Total Shares Change
-7,384
Quarter-by-Quarter History
Other major holders of XBI: BNP PARIBAS FINANCIAL MARKETS, GOLDMAN SACHS GROUP INC